Come up with a name for your new list and we'll add to it:
Ceptaris Therapeutics raised a round of funding on , . Investors include
Advanced Science & Tech Commercialization Center.
Ceptaris Therapeutics, formerly Yaupon Therapeutics, is developing a gel formulation of mechlorethamine hydrochloride (mechlorethamine) for the treatment of early stage (stages I-IIA) mycosis fungoide…